Influence of primary care antibiotic prescribing on incidence rates of multidrug-resistant Gram-negative bacteria in hospitalised patients

被引:5
作者
Alnajjar, Munther S. [1 ,2 ]
Aldeyab, Mamoon A. [3 ]
Scott, Michael G. [4 ]
Kearney, Mary P. [5 ]
Fleming, Glenda [4 ]
Glimore, Fiona [4 ]
Farren, David [5 ]
McElnay, James C. [1 ]
机构
[1] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast BT9 7BL, Antrim, North Ireland
[2] Al Ain Univ Sci & Technol, Dept Clin Pharm, Coll Pharm, Al Ain, U Arab Emirates
[3] Ulster Univ, Sch Pharm & Pharmaceut Sci, Coleraine, Londonderry, North Ireland
[4] Antrim Area Hosp, Medicines Optimisat Innovat Ctr, Trust Headquarters Brettan Hall, Belfast BT41 2RL, Antrim, North Ireland
[5] Antrim Area Hosp, Area Microbiol Lab, Belfast BT41 2RL, Antrim, North Ireland
关键词
Primary care; Antibiotic prescribing; Multidrug-resistant Gram-negative bacteria (MRGN); Hospitalised patients; Antibiotic resistance; Pharmacoepidemiology; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI INFECTION; RISK-FACTORS; STAPHYLOCOCCUS-AUREUS; COMMUNITY;
D O I
10.1007/s15010-019-01305-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose Use of antibiotics can give rise to the selection of resistant bacteria. It remains unclear whether antibiotic use in primary care can influence bacterial resistance incidence in patients when hospitalised. The aim of this study is to explore the impact of prior community antibiotic usage on hospital-detected multidrug-resistant Gram-negative (MRGN) incidence rate. Methods This pharmacoepidemiological study was case-control in design, and was carried out in the Antrim Area Hospital (N. Ireland) in two phases. In phase 1, the controls were matched according to: age, gender, admission ward, date of admission, and age-adjusted Charlson co-morbidity index score. During the second phase, controls were selected randomly from the total population of admissions to the hospital over the 2-year study period. Results In phase 1, multivariate analysis revealed that prior exposure to the second- and third-generation cephalosporins (p = 0.004) and fluoroquinolones (p = 0.023) in primary care was associated with an increased likelihood of MRGN detection in inpatients. In phase 2, an independent relationship between an increased risk of identification of MRGN, while hospitalised was associated with: prolonged hospitalisation (p < 0.001), being elderly (p < 0.001), being female (p = 0.007), and having genitourinary disease (p < 0.001). Conclusion This study provides clear evidence which supports the need to optimise antibiotic use in primary care to help reduce MRGN incidence in hospitalised patients.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 36 条
  • [1] The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings
    Aldeyab, Mamoon A.
    Harbarth, Stephan
    Vernaz, Nathalie
    Kearney, Mary P.
    Scott, Michael G.
    Elhajji, Feras W. Darwish
    Aldiab, Motasem A.
    McElnay, James C.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 171 - 179
  • [2] [Anonymous], 2016, REPORT PEW CHARITABL
  • [3] Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital
    Artero, Arturo
    Esparcia, Ana
    Alberola, Juan
    Madrazo, Manuel
    Nogueira, Jose M.
    Eiros, Jose M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (09)
  • [4] Clinical Risk Score for Prediction of Extended-Spectrum -Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates
    Augustine, Matthew R.
    Testerman, Traci L.
    Justo, Julie Ann
    Bookstaver, P. Brandon
    Kohn, Joseph
    Albrecht, Helmut
    Al-Hasan, Majdi N.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (03) : 266 - 272
  • [5] ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015
    Birgy, Andr
    Levy, Corinne
    Bidet, Philippe
    Thollot, Franck
    Derkx, Veronique
    Bechet, Stephane
    Mariani-Kurkdjian, Patricia
    Cohen, Robert
    Bonacorsi, Stephane
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (10) : 2949 - 2956
  • [6] Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins
    Branger, Catherine
    Ledda, Alice
    Billard-Pomares, Typhaine
    Doublet, Benoit
    Fouteau, Stephanie
    Barbe, Valerie
    Roche, David
    Cruveiller, Stephane
    Medigue, Claudine
    Castellanos, Miguel
    Decre, Dominique
    Drieux-Rouze, Laurence
    Clermont, Olivier
    Glodt, Jeremy
    Tenaillon, Olivier
    Cloeckaert, Axel
    Arlet, Guillaume
    Denamur, Erick
    [J]. MICROBIAL GENOMICS, 2018, 4 (09):
  • [7] Past and Present Perspectives on β-Lactamases
    Bush, Karen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
  • [8] Biology of Clostridium difficile: Implications for Epidemiology and Diagnosis
    Carroll, Karen C.
    Bartlett, John G.
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, VOL 65, 2011, 65 : 501 - 521
  • [9] Worrisome high frequency of extended- spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study
    Castillo-Tokumori, Franco
    Irey-Salgado, Claudia
    Malaga, German
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 55 : 16 - 19
  • [10] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383